Yasuaki Tamura

Prof. Yasuaki Tamura

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
TTTsutomu Tanaka
Tsutomu Tanaka
GKGoro Kutomi
Goro Kutomi
TKToshimitsu Kajiwara
Toshimitsu Kajiwara
KKKazuharu Kukita
Kazuharu Kukita
VKVitaly Kochin
Vitaly Kochin
YTYasuaki Tamura
Yasuaki Tamura
Cancer-associated oxidoreductase ERO1- promotes immune escape through up-regulation of PD-L1 in human breast cancer Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer

15 February 2015 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
TTTsutomu Tanaka
Tsutomu Tanaka
TKToshimitsu Kajiwara
Toshimitsu Kajiwara
TTToshihiko Torigoe
Toshihiko Torigoe
YOYoshiharu Okamoto
Yoshiharu Okamoto
NSNoriyuki Sato
Noriyuki Sato
YTYasuaki Tamura
Yasuaki Tamura
Endoplasmic reticulum disulfide oxidase ERO1-α plays a role in the formation of disulfide bonds in collaboration with protein disulfide isomerase. Disulfide bond formation is required for the proper conformation and function of secreted and cell surface proteins. We found that ERO1-α was overexpressed in a variety of tumor types; therefore, we examined its role in tumor growth. In BALB/c mice, knockdown of ERO1-α within 4T1 mouse mammary gland cancer (KD) cells caused retardation of in vivo tumor growth compared with tumor growth of scrambled control (SCR) cells. In contrast, when ERO1-α–overexpressed 4T1 (OE) cells were compared with mock control cells, OE cells showed augmented tumor growth. However, differences in tumor growth were not observed among four groups of nude mice, suggesting that expression of ERO1-α diminished antitumor immunity. We observed dense peritumoral granulocytic infiltrates in tumors of wild-type 4T1 and SCR cells but not KD cells, and these cells were identified as polymorphonuclear myeloid-derived suppressor cells (MDSCs). In addition, production of G-CSF and CXCL1/2, which have intramolecular disulfide bonds, from KD cells was significantly decreased compared with that from SCR cells. In contrast, OE cells produced a larger amount of these molecules than did mock cells. These changes were regulated at the posttranscriptional level. These results suggest that overexpression of ERO1-α in the tumor inhibits the T cell response by recruiting polymorphonuclear MDSCs via regulation of MDSC-prone cytokines and chemokines.

1 August 2018 in Asian-Australasian Journal of Animal Sciences
Verified
Journal Article
Open access
PDF file
KHKenji Hosoda
Kenji Hosoda
HSHideki Sasahara
Hideki Sasahara
KMKei Matsushita
Kei Matsushita
YTYasuaki Tamura
Yasuaki Tamura
MMMakoto Miyaji
Makoto Miyaji
HMHiroki Matsuyama
Hiroki Matsuyama
An experiment was conducted to assess the antioxidant contents and activities of colored rice grains and to evaluate their nutritive characteristics in terms of chemical composition and in situ ruminal degradation. Ten cultivars of colored rice grains (Oryza sativa L.) collected from several areas of Japan were studied, and control rice without pigment, maize, barley, and wheat grains were used as control grains. Their chemical compositions, pigment, polyphenol contents, total antioxidant capacity (TAC), and degradation characteristics were determined. The starch contents of the colored rice grains were in the range of 73.5% to 79.6%, similar to that of the control rice grain. The black and red rice grains contained anthocyanin (maximum: 5,045.6 μg/g) and proanthocyanidin (maximum: 3,060.6 μg/g) at high concentrations as their principal pigments, respectively. There were significantly (pbarley ≥rice>maize. The colored rice grains also included the most-digestible starch, since their potential degradable fraction and actual degradability at 48 h incubation were almost 100%. Colored rice grains have high potential to be used as antioxidant sources in addition to starch sources in ruminants.

15 May 2015 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
KKKazuharu Kukita
Kazuharu Kukita
YTYasuaki Tamura
Yasuaki Tamura
TTTsutomu Tanaka
Tsutomu Tanaka
TKToshimitsu Kajiwara
Toshimitsu Kajiwara
GKGoro Kutomi
Goro Kutomi
NSNoriyuki Sato
Noriyuki Sato
ERO1-α is an oxidizing enzyme that exists in the endoplasmic reticulum and is induced under hypoxia. It reoxidizes the reduced form of protein disulfide isomerase that has oxidized target proteins. We found that ERO1-α is overexpressed in a variety of tumor types. MHC class I H chain (HC) has two disulfide bonds in the α2 and α3 domains. MHC class I HC folding is linked to the assembly of MHC class I molecules because only fully disulfide-bonded class I HCs efficiently assemble with β2-microglobulin. In this study, we show that ERO1-α associates with protein disulfide isomerase, calnexin, and immature MHC class I before being incorporated into the TAP-1–associated peptide-loading complex. Importantly, ERO1-α regulates the redox state as well as cell surface expression of MHC class I, leading to alteration of susceptibility by CD8+ T cells. Similarly, the ERO1-α expression within cancer cells was associated with the expression level of MHC class I in colon cancer tissues. Thus, the cancer-associated ERO1-α regulates the expression of the MHC class I molecule via oxidative folding

13 April 2015 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
KSKeita Saito
Keita Saito
KKKazuharu Kukita
Kazuharu Kukita
GKGoro Kutomi
Goro Kutomi
KOKoichi Okuya
Koichi Okuya
HAHiroko Asanuma
Hiroko Asanuma
YTYasuaki Tamura
Yasuaki Tamura
Systemic lupus erythematosus (SLE) is a prototype systemic autoimmune disease, and disease activity is associated with serum IFN‐α level. Plasmacytoid dendritic cells (pDCs) sense microbial as well as self‐nucleic acids by TLRs 7 and 9 and produce a large amount of IFN‐α. Here, we show that heat shock protein 90 (Hsp90) associates with and delivers TLR7/9 from the ER to early endosomes for ligand recognition. Inhibition of Hsp90 by various approaches including the use of Hsp90 inhibitor, a geldanamycin derivative, suppressed the Hsp90 association with TLR7/9, which resulted in inhibition of IFN‐α production, leading to improvement of SLE symptoms in mice. Notably, we observed that serum Hsp90 is clearly increased in patients with active SLE compared with that in patients with inactive disease. Furthermore, we demonstrated that serum Hsp90 detected in SLE patients binds to self‐DNA and/or anti‐DNA Ab, thus leading to stimulation of pDCs to produce IFN‐α. Our data demonstrate that Hsp90 plays a crucial role in the pathogenesis of SLE and that an Hsp90 inhibitor will therefore provide a new therapeutic approach to SLE and other nucleic acid‐related autoimmune diseases.

20 August 2013 in Pathology International
Verified
Journal Article
Open access
PDF file
JMJunichi Matsuzaki
Junichi Matsuzaki
Toshihiko TorigoeToshihiko Torigoe
Toshihiko Torigoe
Yoshihiko HirohashiYoshihiko Hirohashi
Yoshihiko Hirohashi
YTYasuaki Tamura
Yasuaki Tamura
HAHiroko Asanuma
Hiroko Asanuma
NSNoriyuki Sato
Noriyuki Sato
We have shown that ECRG4 suppressed Fas-induced apoptosis in Jurkat cells. ECRG4 mRNA expression was ubiquitously detected in normal adult human tissues, suggesting that ECRG4 plays a major role in human tissues. ECRG4 mRNA expression was down-regulated in tumor cells. Expression of ECRG4 suppressed cell growth. We established an anti-ECRG4 monoclonal antibody. Our immunohistochemical analysis demonstrated that ECRG4-positive cells tended to be distributed in the region that was negative for Ki-67 in esophageal squamous cell carcinoma tissues. There was a significant inverse correlation between ECRG4 expression and Ki-67 labeling index in esophageal squamous cell carcinoma. This study provides the first functional evidence for an association of endogenous expression of ECRG4 with cell proliferation. ECRG4 is a candidate tumor suppressor gene that might be involved in the proliferation of esophageal squamous cell carcinoma.